A multidimensional analysis of prognostic factors in atopic dermatitis

A multidimensional analysis of prognostic factors in atopic dermatitis

Atopic dermatitis (AD) is a chronic inflammatory skin condition with a high prevalence worldwide and multifaceted pathogenesis. In general, patients with moderate to severe AD often experience relapse after discontinuing treatment. Therefore, to understand the possible factors of chronic relapse of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhenggang Liu, Mengnan Guo, Yumei Li, Hui Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Medicine
Subjects:	atopic dermatitis signal transducer and activator of transcription general factors IL-9-IL-18 axis prognostic biomarkers ceramide profiles
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1554669/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immune response in atopic dermatitis: main pathogenetic mechanisms and stage-dependent correlations with age in regard to dermatological and non-dermatological systemic processes
by: M. B. Drozhdina, et al.
Published: (2021-05-01)

Innovations in the Therapy of Atopic Dermatitis Complicated by a Secondary Infection
by: Nikolay N. Murashkin, et al.
Published: (2018-10-01)

Probiotics for the Treatment of Atopic Dermatitis in Adults: A Systematic Review and Meta-Analysis
by: Chen Yingying, et al.
Published: (2025-07-01)

Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis
by: Carlota Abbad-Jaime de Aragon, et al.
Published: (2025-12-01)

Advancing Therapeutic Strategies in Atopic Dermatitis: Emerging Targets and Personalized Approaches
by: Yang Lo, et al.
Published: (2025-06-01)

Pathogenetic role of IL-4 and IL-13 in atopic dermatitis: The inhibitory pathways
by: D. Sh. Macharadze
Published: (2025-03-01)

Real‐life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety
by: Eulalia Baselga Torres, et al.
Published: (2025-06-01)

Filaggrin and Atopic Dermatitis: Clinical and Pathogenetic Parallels and Therapeutic Possibilities
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01)

A case of concurrent exacerbation of manifestations and asthma after the initiation of nemolizumab treatment for atopic dermatitis
by: Michie Katsuta, MD, et al.
Published: (2025-07-01)

The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)
by: Jennifer Soung, et al.
Published: (2025-07-01)

Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
by: Ga Hee Jeong, et al.
Published: (2025-01-01)

Incidence of upper respiratory tract infections with biological therapies in moderate to severe atopic dermatitis: a systematic review and meta-analysis
by: Rose Alraddadi, et al.
Published: (2025-04-01)

NFATc1 deficiency in B cells ameliorates atopic dermatitis
by: Hidaya Abdul Kader, et al.
Published: (2025-07-01)

Severity of atopic dermatitis is associated with gut-derived metabolites and leaky gut-related biomarkers
by: Leszek Blicharz, et al.
Published: (2025-07-01)

The diagnosis and management of atopic dermatitis
by: H.F. Jordaan, et al.
Published: (2009-10-01)

Profile of Transepidermal Water Loss in Non-Atopic Dermatitis and Atopic Dermatitis in Indonesian Adults
by: Damayanti, et al.
Published: (2025-03-01)

Contemporary therapeutic approaches to atopic dermatitis: role of phototherapy and searching for new possibilities
by: I. V. Kosheleva, et al.
Published: (2021-06-01)

Therapeutic potential of cannabinoids for treating atopic dermatitis
by: Adriel Aparecido Geraldo Stoco, et al.
Published: (2025-08-01)

Overlap syndrome of atopic dermatitis and allergic contact dermatitis: metabolic patterns
by: L.V. Konovalenko, et al.
Published: (2025-06-01)

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

Allergen-specific circulating CLA+ memory T cells stratify IL-22 response in atopic dermatitis skin
by: Irene García-Jiménez, et al.
Published: (2025-07-01)

Update Management of Atopic Dermatitis
by: Indri Widya Sari, et al.
Published: (2024-11-01)

Genetic Variant rs1801275 in Atopic Dermatitis: Prevalence and Clinical Implications in Vietnamese Population
by: Nguyen THN, et al.
Published: (2025-06-01)

Biomarkers in Atopic Dermatitis in Children: A Comprehensive Review
by: Cristiana Indolfi, et al.
Published: (2025-02-01)

Lebrikizumab Rapidly Lowers Inflammatory Biomarkers with Clinical Correlations in Moderate-to-Severe Atopic Dermatitis
by: Emma Guttman-Yassky, et al.
Published: (2025-07-01)

Integrated Multi-Omics Analyses Reveal Innovative Diagnostic and Therapeutic Targets Associated with Atopic Dermatitis
by: Chen X, et al.
Published: (2025-06-01)

Response to Comments on The Association of Inflammatory Indexes Derived From Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis [Response to Letter]
by: Zhang L, et al.
Published: (2025-03-01)

Childhood Atopic Dermatitis in Taiwan
by: I-Jen Wang, et al.
Published: (2016-04-01)

Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?
by: Joseph F. Fowler, et al.
Published: (2025-12-01)

«Skin window» cytokines in atopic dermatitis
by: D. S. Zagreshenko, et al.
Published: (2009-06-01)

Therapy and mechanism of natural polysaccharides for atopic dermatitis treatment
by: Wenjie Wang, et al.
Published: (2025-05-01)

Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals
by: Giovanni Paolino, et al.
Published: (2024-12-01)

INFLAMMASOME NLRP1 DISTINCTIVE FEATURES IN ATOPIC CONDITIONS
by: Денис Сергеевич Загрешенко, et al.
Published: (2023-08-01)

The Role of the Skin Microbiome in Pathogenesis of Atopic Dermatitis - Current State of Knowledge
by: Natalia Sidz, et al.
Published: (2025-06-01)

Unraveling the gut-skin axis in atopic dermatitis: exploiting insights for therapeutic strategies
by: Marcela Rios-Carlos, et al.
Published: (2024-12-01)

Correlation between Allergic Rhinitis and History of Infantile Atopic Dermatitis
by: Mutiara Arikah Balqis, et al.
Published: (2025-03-01)

CLINICAL AND DIAGNOSTIC VALUE OF DETERMINATION OF NEOPTERIN IN ATOPIC DERMATITIS IN CHILDREN
by: M. M. BEN, et al.
Published: (2018-07-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

A systematic review of guidelines for the management of atopic dermatitis in children
by: Maya Deva, MBBS, et al.
Published: (2024-12-01)

Epidemiology and Burden of Pediatric Atopic Dermatitis in China
by: Chien-Chia Chuang, et al.
Published: (2025-04-01)